8-K
Current Report
Foghorn Therapeutics Inc. Filed Acc 0001193125-20-303604
Material agreement · New debt or obligation · Unregistered share sale
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading d10278d8k.htm…